Schedule 13D ownership disclosure

NEWAMSTERDAM PHARMA COMPANY

Security class unavailable · CUSIP: N62509109

Event date: 2024-11-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-259852
Form type
SC 13D/A
Filer
Forbion Capital Fund IV Cooperatief U.A.
CIK
CIK 1823747
Filed
Nov 15, 2024
Reporting period
Nov 13, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub